Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Launched by UNIVERSITY OF PITTSBURGH · Sep 12, 2005
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on collecting blood, urine, and tissue samples from patients diagnosed with certain skin conditions, specifically cutaneous T-cell lymphoma (CTCL), eczema, and atopic dermatitis. The goal is to gather these samples for current and future research, which may help improve our understanding and treatment of these conditions. The study is currently looking for participants who are at least 18 years old and can give their consent to join.
To be eligible for the trial, you must have a diagnosis of CTCL, eczema, or atopic dermatitis. Unfortunately, if you do not have one of these conditions, you won't be able to participate. If you join the study, you will provide samples that researchers can use to learn more about these skin diseases. This research could lead to better treatments in the future. Your participation could play an important role in advancing medical knowledge and improving care for patients with these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 or older
- • able and willing to provide informed consent
- • diagnosed with CTCL
- • diagnosed with either atopic dermatitis or eczema
- Exclusion Criteria:
- • Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Oleg E Akilov, M.D., PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials